1 / 23

NHS Evidence What it means for you

NHS Evidence What it means for you. Dr Gillian Leng Deputy Chief Executive June 2009. HTA. Bandolier. JAMA. Map of Medicine. NICE. SIGN. PubMed. Healthcare Commission. Department of Health. Cochrane. DUETs. DARE. CKS. BNF. Economic Evaluation Database. BMJ.

amish
Download Presentation

NHS Evidence What it means for you

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NHS EvidenceWhat it means for you Dr Gillian Leng Deputy Chief Executive June 2009

  2. HTA Bandolier JAMA Map of Medicine NICE SIGN PubMed Healthcare Commission Department of Health Cochrane DUETs DARE CKS BNF Economic Evaluation Database BMJ The challenge of multiple sources of information NHS Evidence NHS Evidence NHS Evidence will sort, sift and prioritise information according to user needs

  3. Categories of information in NHS Evidence Clinical Commissioning & Improvement • Service guidance • Tools & models • Care pathways • Indicators & metrics • Improvement information • Guidelines • Systematic Reviews • Other synthesises content (summaries & overviews) • Primary research and ongoing trials Social care E-Learning & Education • Social care information – assured by SCIE • On-line learning modules Drug & Technologies Public Health • Prescribing & safety information • Technology appraisals • Significant new drugs • Devices, diagnostics & IP guidance • Public Health guidance • Systematic reviews • Primary research

  4. HTA Bandolier SIGN Map of Medicine NICE PubMed JAMA Healthcare Commission DUETs Department of Health Cochrane DARE NeLM CKS BNF Economic Evaluation Database BMJ Sources Technology Sorting, Sifting and Prioritising NHS Evidence

  5. Sorting, sifting and prioritising • Exclusion - only those sources likely to present significantly biased opinions • Sorting, sifting and prioritising - three approaches: • A formal system for accrediting producers of ‘guidance’, to enable the best, most trusted sources to be easily recognisable through an accreditation mark • A process for regularly reviewing new publications across a range of topic areas, to highlight significant new evidence on a monthly and annual basis • An effective approach to searching for information and ranking search returns by relevancy and quality.

  6. Transparent and based on standardised criteria and processes Unbiased with oversight by an independent Advisory Board Initially focused on ‘guidelines’ sources of evidence Based on the process used to develop evidence  Sources will be accredited, rather than individual articles NHS Evidence accreditation scheme NHS Evidence Accreditation Scheme Key aim: to identify trusted sources of information and set best practice standards Kitemark will become well-known and recognised

  7. Draft criteria – based on AGREE • Scope and process – clearly defined • Stakeholder engagement policy • Rigorous development process – including systematic searching, inclusion/exclusion criteria etc • Recommendations clearly presented • Applicability considered • Reliable – absence of bias

  8. Highlighting new publications • Alerts through RSS feeds • Significant new information highlighted by topic experts (Specialist Collections) via: • - Web alerts • - Monthly newsletters, in context • - Annual evidence updates

  9. There are 34 Specialist Collections 18 of these are focused on clinical conditions 5 are focused on specific patient groups 11 are focused on aspects of health services

  10. Effective searching • Principle objective - to present the user with the most relevant results on the first page. • Relevancy of the information returned is largely informed by the search engine – produces results as close a match as possible to the user’s requirements. •  Ranking policy – to promote certain records higher within the list of search returns and improve the searching experience.

  11. Rolling out NHS Evidence Oct 08 Nov • Full development of NHS Evidence will take several years – to set up systems for clinical engagement and to organise and sort the vast range of information sources • Initial launch of NHS Evidence in April 2009 includes: • A fast, comprehensive search function for clinical and non-clinical information • Access to a resource collating information on new drugs to support commissioners • Opportunity to rate search results • Links to all previous NLH resources Dec Jan 09 Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2010 2011 2012

  12. www.evidence.nhs.uk

  13. Results can be filtered by: • Area of interest: • Clinical, Public Health, Commissioning etc • Type of information: • Systematic reviews, drug information, ongoing trials etc • Clinical query: • Diagnosis, therapy, prognosis etc • Sources: • Cochrane, BNF, CKS etc • Medicines and devices: • Lists relevant drug names

  14. Release 2 – Key IT deliverables

  15. Key functions of NHS Evidence • In summary, NHS Evidence will: • Provide comprehensive access to information in health and social care via a web-based portal • Commission the development and collation of evidence-based information from external agencies • Provide a central purchasing function for journals • Provide a formal accreditation scheme • Identify evidence reflecting best practice • Engage with users and stakeholders to support the use of evidence in decision-making, and to provide feedback to develop the service Better decisions to improve health and healthcare

  16. And finally… • ….what this means for you • Better access to information about new products - drugs, devices, services etc • On-line information to ongoing trials • Ability to share information about local innovations, by uploading onto NHS Evidence

More Related